Background: The emerging use of biomarkers in research and tailored care introduces a need for information about the association between biomarkers and basic demographics and lifestyle factors revealing expectable concentrations in healthy individuals while considering general demographic differences. Methods: A selection of 47 biomarkers, including markers of inflammation and vascular stress, were measured in plasma samples from 9876 Danish Blood Donor Study participants. Using regression models, we examined the association between biomarkers and sex, age, Body Mass Index (BMI), and smoking. Results: Here we show that concentrations of inflammation and vascular stress biomarkers generally increase with higher age, BMI, and smoking. Sex-specific effects are observed for multiple biomarkers. Conclusion: This study provides comprehensive information on concentrations of 47 plasma biomarkers in healthy individuals. The study emphasizes that knowledge about biomarker concentrations in healthy individuals is critical for improved understanding of disease pathology and for tailored care and decision support tools.
: Transcriptional characterization and classification has potential to resolve the inter-tumor heterogeneity of colorectal cancer and improve patient management. Yet, robust transcriptional profiling is difficult using formalin-fixed, paraffin-embedded (FFPE) samples, which complicates testing in clinical and archival material. We present MethCORR, an approach that allows uniform molecular characterization and classification of fresh-frozen and FFPE samples. MethCORR identifies genome-wide correlations between RNA expression and DNA methylation in fresh-frozen samples. This information is used to infer gene expression information in FFPE samples from their methylation profiles. MethCORR is here applied to methylation profiles from 877 fresh-frozen/FFPE samples and comparative analysis identifies the same two subtypes in four independent cohorts. Furthermore, subtype-specific prognostic biomarkers that better predicts relapse-free survival (HR = 2.66, 95%CI [1.67–4.22], P value < 0.001 (log-rank test)) than UICC tumor, node, metastasis (TNM) staging and microsatellite instability status are identified and validated using DNA methylation-specific PCR. The MethCORR approach is general, and may be similarly successful for other cancer types.
The Copenhagen Hospital Biobank-chronic inflammatory disease—inflammatory bowel disease (CHB-CID: IBD) cohort contributes to genetic research in inflammatory bowel disease, including Crohn’s disease and ulcerative colitis. Of the 327,084 enrolled and genotyped individuals in the cohort, 10,626 have been diagnosed with IBD as of May 2023. The CHB-CID: IBD cohort includes both patients without IBD and healthy blood donors as control groups. Clinical data is collected from Danish registries and patient records, including details on hospital contacts, co-morbidities, medication, surgical procedures, and laboratory investigations. The cohort features a wide age range (> 18 years), extensive population coverage representative of Danish adults, and validated IBD diagnoses. Finally, the cohort benefits from continuous recruitment and regular updates of clinical information. The aim is to enhance IBD management and ultimately improve patients’ quality of life.
Background: Blood donation causes iron loss and increases the risk of non‐anemic iron deficiency (NAID), which is not detected by hemoglobin screening alone. Evidence linking NAID to fatigue and insomnia symptoms in healthy blood donors remains limited and inconsistent. We aimed to investigate these associations in a large cohort of Danish blood donors. Study design and methods: This cross‐sectional study used data from the Danish Blood Donor Study collected from May 2015 to January 2025. Donors with both a ferritin measurement and questionnaire data on fatigue and insomnia within 90 days of the measurement were included. NAID was defined as ferritin <15 μg/L with normal hemoglobin level. Sex‐stratified multivariable logistic regression models were adjusted for age, body mass index, smoking status, region, and donation history. Ferritin was also modeled continuously using linear spline regression. Results: Among 59,668 donors, NAID was present in 9.5% of women and 2.0% of men. NAID was associated with fatigue among women (OR 1.22, 95% CI 1.06–1.40) and insomnia symptoms among men (OR 1.26, 95% CI 1.03–1.53). Continuous analyses suggested that lower ferritin concentrations were associated with higher odds of fatigue in both sexes and higher odds of insomnia symptoms in men. Conclusion: Low iron stores in non‐anemic blood donors were associated with fatigue in women and insomnia symptoms in men. These findings suggest that hemoglobin screening alone may be insufficient to identify donors with symptomatic iron depletion and support consideration of ferritin monitoring as part of donor health strategies.